Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg

NCT00648024 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Anagrelide Hydrochloride Capsules 1 mg
DRUG: Agrylin® Capsules 1 mg

Sponsor

Mylan Pharmaceuticals Inc